|Day Low/High||97.10 / 98.44|
|52 Wk Low/High||81.37 / 106.67|
Cramer shares his views on Target's excuses. Apple, CVS and Urban Outfitters are among the stocks discussed.
This week Whirlpool jumped into the portfolio pool, where it joined recent additions Sherwin-Williams and International Flavors & Fragrances.
Company to deploy mobile pharmacy and other in-kind needs to hard hit communities
Target's big move to profit from installing CVS pharmacies in its stores hit a speed bump in the second quarter.
This was the quarter of bricks-and-mortar retail -- just not Target's bricks and mortar.
Target's sales declined in the second quarter amid a challenging retail environment.
Nearly 40 CVS Pharmacy locations in Colorado can now dispense naloxone
Becton Dickinson, CVS and General Dynamics offer value even after the recent run-up in stocks.
Convenience found to be major factor in determining where Americans get a flu shot
Earlier this month the two major pharmacy benefit managers, CVS Caremark CVS and Express Scripts ESRX released lists of drugs they will no longer cover in 2017.
This week we promoted International Flavors & Fragrances from the Bullpen and added it to our active portfolio, where it joined recent newbie Sherwin-Williams.
Even though overall sales were weaker than expected, the underlying shifts that are at the heart of several of our positions remain very much intact.
CVS Pharmacy is now located inside Target stores in Nampa and Twin Falls
New CVS Pay pilot enables customers to receive ExtraCare deals, pick-up prescriptions and pay - all with one scan at checkout
CVS Health's (CVS) earnings estimates were increased at Leerink this morning as the firm said it continues 'to be positive on CVS' long-term fundamentals.'
A blowout July jobs report helped push both the S&P 500 and Nasdaq to record high closes on Friday.
We welcomed paint maker Sherwin-Williams into the Trifecta portfolio fold this week.
Here's a technical look at how to trade five large-cap stocks that are nearing breakout buy signals.
Company earnings in line while revenues miss in 'beleaguered oil environment.'
CVS Health announced on Tuesday that it was stopping coverage of 35 new drugs in 2017 and 131 in total, up from 124 in 2016.
CVS Health (CVS) stock earnings estimates were increased at Barclays this morning after reporting 2016 second quarter results Tuesday.
Another selloff in crude oil and a disappointing July for automakers kept stocks firmly in the red on Tuesday in what has been a disappointing start to August.
Stocks hold near session lows by late Tuesday as crude oil closes below $40 a barrel for the first time since April.
Markets were falling as oil prices continued their two-month descent below $40 a barrel.
U.S. stocks extended losses as auto sales in July disappointed, a rare miss after months of blowout growth.